StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Free Report) in a research report report published on Saturday morning. The brokerage issued a sell rating on the stock.
Ampio Pharmaceuticals Price Performance
AMPE opened at $0.00 on Friday. Ampio Pharmaceuticals has a fifty-two week low of $0.00 and a fifty-two week high of $7.47. The firm has a market cap of $2,497.00, a PE ratio of 0.00 and a beta of 3.67.
Ampio Pharmaceuticals Company Profile
Read More
- Five stocks we like better than Ampio Pharmaceuticals
- Conference Calls and Individual Investors
- Why Lennar Stock Could Be the Best Play in the Housing Market
- What is Insider Trading? What You Can Learn from Insider Trading
- 2 Energy Stocks Fueling the AI Datacenter Boom
- When to Sell a Stock for Profit or Loss
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
